Inventor · disambiguated record
David M. Armistead
Also filed as: ARMISTEAD DAVID · ARMISTEAD DAVID M
33 granted patents·12 pending applications·1,818 citations·filing 1991–2024
98Inventor score
Files withVERTEX PHARMA23AMGEN INC5GILEAD CONNECTICUT INC4REVOLUTION MEDICINES INC4MITCHELL SCOTT A2
Top patents by PatentIndex Score
45 records- 0199US6054472AInhibitors of IMPDH enzymeVERTEX PHARMA·Filed 1997·Granted Apr 25, 2000·242 cites·12 claims
- 0298US7282504B2Kinase inhibitorsAMGEN INC·Filed 2005·Granted Oct 16, 2007·90 cites·11 claims
- 0398US5807876AInhibitors of IMPDH enzymeVERTEX PHARMA·Filed 1996·Granted Sep 15, 1998·304 cites·21 claims
- 0497US10989710B2Identifying new therapeutic agentsREVOLUTION MEDICINES INC·Filed 2018·Granted Apr 27, 2021·14 cites·6 claims
- 0597US10203323B2Identifying new therapeutic agentsWARP DRIVE BIO INC·Filed 2016·Granted Feb 12, 2019·21 cites·6 claims
- 0697US9428845B1Identifying new therapeutic agentsVERDINE GREGORY L·Filed 2011·Granted Aug 30, 2016·28 cites·8 claims
- 0796US8748607B2Imidazopyrizine syk inhibitorsGILEAD CONNECTICUT INC·Filed 2013·Granted Jun 10, 2014·34 cites·13 claims
- 0896US8455493B2Imidazopyrazine Syk inhibitorsMITCHELL SCOTT A·Filed 2009·Granted Jun 4, 2013·55 cites·10 claims
- 0996US6541496B1Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2000·Granted Apr 1, 2003·80 cites·12 claims
- 1096US6344465B1Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 1997·Granted Feb 5, 2002·186 cites·9 claims
- 1196US5620971ABiologically active acylated amino acid derivativesVERTEX PHARMA·Filed 1994·Granted Apr 15, 1997·88 cites·27 claims
- 1296US5516797AImmunosuppressive compoundsVERTEX PHARMA·Filed 1994·Granted May 14, 1996·121 cites·8 claims
- 1396US5330993AImmunosuppressive compoundsVERTEX PHARMA·Filed 1991·Granted Jul 19, 1994·143 cites·1 claims
- 1495US11644460B2Identifying new therapeutic agentsREVOLUTION MEDICINES INC·Filed 2020·Granted May 9, 2023·8 cites·10 claims
- 1595US9796718B26-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amineGILEAD CONNECTICUT INC·Filed 2015·Granted Oct 24, 2017·14 cites·2 claims
- 1689US7074789B2Kinase inhibitorsAMGEN INC·Filed 2003·Granted Jul 11, 2006·25 cites·7 claims
- 1789US2025076289A1Identifying new therapeutic agentsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 1887US7329681B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2005·Granted Feb 12, 2008·8 cites·11 claims
- 1987US6495558B1Kinase inhibitorsAMGEN INC·Filed 2000·Granted Dec 17, 2002·18 cites·5 claims
- 2086US5665774AImmunosuppressive compoundsFiled 1993·Granted Sep 9, 1997·42 cites·18 claims
- 2185US2024044876A1Identifying new therapeutic agentsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 2284US5978740AMolecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying themVERTEX PHARMA·Filed 1995·Granted Nov 2, 1999·45 cites·6 claims
- 2384US5717092ACompounds with improved multi-drug resistance activityVERTEX PHARMA·Filed 1996·Granted Feb 10, 1998·54 cites·3 claims
- 2482US6326387B1Methods and compositions for stimulating neurite growthVERTEX PHARMA·Filed 2000·Granted Dec 4, 2001·13 cites·20 claims
- 2581US6967214B2Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2003·Granted Nov 22, 2005·12 cites·38 claims
- 2681US5723459ABiologically active acylated amino acid derivativesVERTEX PHARMA·Filed 1995·Granted Mar 3, 1998·28 cites·28 claims
- 2780US6128582AMolecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying themVERTEX PHARMA·Filed 1996·Granted Oct 3, 2000·33 cites·11 claims
- 2876US6037370AMethods and compositions for stimulating neurite growthVERTEX PHARMA·Filed 1995·Granted Mar 14, 2000·33 cites·11 claims
- 2971US6518291B1Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 1999·Granted Feb 11, 2003·30 cites·12 claims
- 3066US7527952B2Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid (IIMPDH/XMP*/MPA)VERTEX PHARMA·Filed 2006·Granted May 5, 2009·0 cites·2 claims
- 3164US6124328AMethods and compositions for stimulating neurite growthVERTEX PHARMA·Filed 1997·Granted Sep 26, 2000·16 cites·13 claims
- 3264US2018086769A1Imidazopyrazine syk inhibitorsGILEAD CONNECTICUT INC·Filed 2017·Application pending·0 cites
- 3359US5932600AInhibitors of IMPDH enzymeVERTEX PHARMA·Filed 1997·Granted Aug 3, 1999·22 cites·12 claims
- 3459US2009221612A1Certain substituted amides, method of making, and method of use thereofMITCHELL SCOTT A·Filed 2009·Application pending·0 cites
- 3556US2007010952A1Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying themARMISTEAD DAVID M·Filed 2006·Application pending·0 cites
- 3653US5935954ACompounds with improved multi-drug resistance activityVERTEX PHARMA·Filed 1997·Granted Aug 10, 1999·9 cites·16 claims
- 3752US2003199534A1Kinase inhibitorsAMGEN INC·Filed 2003·Application pending·0 cites
- 3851US7216041B1Methods of using the structure coordinates of molecules comprising an IMPDH-like binding pocketVERTEX PHARMA·Filed 2000·Granted May 8, 2007·0 cites·30 claims
- 3950US2013267496A1Imidazopyrazine syk inhibitorsGILEAD CONNECTICUT INC·Filed 2013·Application pending·0 cites
- 4049US2004048774A1Inhibitors of IMPDH enzymeVERTEX PHARMA·Filed 2003·Application pending·0 cites
- 4148US2003004174A9Kinase inhibitorsFiled 2001·Application pending·0 cites
- 4247US2004170981A1Real-time polymerase chain reaction using large target ampliconsFiled 2003·Application pending·0 cites
- 4347US2004170954A1Pathogen inactivation assayFiled 2003·Application pending·0 cites
- 4447US2004019067A1Kinase inhibitorsAMGEN INC·Filed 2002·Application pending·0 cites
- 4540US7065452B1Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying themVERTEX PHARMA·Filed 1999·Granted Jun 20, 2006·2 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when David M. Armistead files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →